Thalidomide-4-NH-PEG1-NH2 TFA is a versatile thalidomide derivative featuring an amino-PEG1 linker at the 4-amino position, ending in a terminal amine functional group and provided as the TFA salt. Specifically engineered for use in PROTAC (Proteolysis Targeting Chimera) and molecular glue research, this compound serves as a ligand for the E3 ubiquitin ligase cereblon (CRBN), a key component in targeted protein degradation. The PEG1 spacer enhances solubility and flexibility, allowing for efficient conjugation with various target-binding moieties in the synthesis of bifunctional degraders. Thalidomide-4-NH-PEG1-NH2 TFA is ideal for researchers developing next-generation CRBN-based PROTACs for exploring novel therapeutic applications and protein knockdown strategies in cell biology and drug discovery.
Structure of 2490499-21-1
* For research and manufacturing use only. Not for human or clinical use.
| Size | Price | Stock | Quantity |
|---|---|---|---|
| -- | $-- | In stock |
Looking for different specifications? Click to request a custom quote!
Capabilities & Facilities
Popular Publications Citing BOC Sciences Products
Background Introduction
Thalidomide-4-NH-PEG1-NH2 TFA is a functionalized derivative of thalidomide that has been modified at the 4-amino position with a monodisperse polyethylene glycol (PEG1) chain terminating in a primary amine. The presence of the TFA (trifluoroacetic acid) salt form ensures enhanced solubility and stability for synthetic applications. As a CRBN (Cereblon) E3 ligase ligand, this compound is a valuable building block for the development of PROTACs (Proteolysis Targeting Chimeras), enabling targeted protein degradation.
Mechanism
Thalidomide-4-NH-PEG1-NH2 TFA binds specifically to the CRBN (Cereblon) substrate receptor of the CRL4^CRBN E3 ubiquitin ligase complex. This ligand enables the recruitment of CRBN to PROTAC molecules. The PEG1 linker offers improved solubility and spatial flexibility, while the terminal primary amine allows straightforward coupling to a variety of target protein ligands. By bridging CRBN and the target protein ligand, it facilitates proximity-dependent ubiquitination and subsequent proteasomal degradation of the target protein.
Applications
Thalidomide-4-NH-PEG1-NH2 TFA is widely used for the synthesis of CRBN-recruiting PROTACs and related heterobifunctional degraders. Its unique PEG1 linker improves overall pharmacokinetic properties, cell permeability, and water solubility of chimeric molecules. This compound is ideal for:
• Construction of CRBN-based protein degrader libraries
* Our calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2
Please contact us with any specific requirements and we will get back to you as soon as possible.